Alteplase, a tissue plasminogen activator (tPA), exerts thrombolytic effects in stroke treatment through fibrin‐specific fibrinolysis, restoration of cerebral perfusion, attenuation of inflammatory responses, and blood–brain barrier preservation [78]. The gene discussed is PLAT; the disease is Stroke.